Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Top Ten most popular articles on Pharmafile.com this week!

February 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMR, Dame Sally Davies, FDA, FMD, antibiotic resistance, esketamine, falsified medicines, top 10

News that the FDA’s advisory panel had recommended Janssen’s intranasal esketamine spray Spravato as a treatment for treatment resistant depression, …
News

Roche’s Perjeta secures NICE approval in adjuvant HER2+ metastatic breast cancer

February 15, 2019 Medical Communications, Sales and Marketing NICE, Perjeta, Roche, pharma

NICE has announced its decision to authorise the use of Roche’s Perjeta (pertuzumab) on the NHS for the treatment of …
News

Takeda’s Adcetris secures expanded approval in Europe for untreated CD30+ Stage IV Hodgkin lymphoma

February 14, 2019 Sales and Marketing Adcetris, Cancer, Europe, Hodgkin lymphoma, Takeda, pharma

Takeda’s Adcetris (brentuximab vedotin) has seen its marketing authorisation expanded by the European Commission to include the treatment of previously …
News

FDA approves Novartis’ Egaten for parasitic infection fascioliasis

February 14, 2019 Sales and Marketing Egaten, FDA, Novartis, fascioliasis, pharma

The FDA has taken the decision to authorise the use of Novartis’ Egaten (triclabendazole) in patients older than six years …
News

Clinigen becomes sole license holder of cancer drug Proleukin in $210m deal

February 14, 2019 Sales and Marketing Clinigen, Novartis, Proleukin, pharma

Novartis has arranged to sell the remainder of its rights to its skin and lung cancer drug Proleukin (aldesleukin, recombinant …
News

J&J acquires lung cancer-focused robotics firm Auris Health in potential $5.75m deal

February 14, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Auris Health, Cancer, J&J, JJ, lung cancer, pharma, robotics

In a bid to bolster its footing in providing surgical treatments, Johnson & Johnson has announced it will acquire robotics …
News

BMS scores expanded European approval for Sprycel in paediatric leukaemia

February 13, 2019 Research and Development, Sales and Marketing BMS, Cancer, Europe, Sprycel, leukaemia, pharma

Bristol-Myers Squibb’s Sprycel (dasatinib) has secured an expanded indication in Europe, the company said, with the European Commission greenlighting the …
News

Janssen’s esketamine drug recommended by FDA panel for depression

February 13, 2019 Research and Development, Sales and Marketing FDA, Janssen, Spravato, depression, esketamine, major depressive disorder, pharma

In a rare and welcomed development in the treatment of major depressive disorder (MDD), Janssen has announced that its esketamine …
News

Sanofi name current CMO Dr Ameet Nathwani as new Chief Digital Officer

February 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

French firm Sanofi has appointed pharma veteran Dr Ameet Nathwani to the position of Chief Digital Officer. In his new …
Appointment

Gilead’s CAR-T therapy Yescarta rejected for NHS use in Scotland

February 12, 2019 Manufacturing and Production, Sales and Marketing CAR-T, Cancer, Gilead, NHS, Scotland, Yescarta, kite pharma

It’s bad news for Scottish patients living with aggressive forms of non-Hodgkin lymphoma (NHL) as it emerges that the Scottish …
News

Solving the drug development problem

February 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, drug discovery, feature, pharma, pistoia alliance

Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …
Feature

Vertex doubles Q4 profits, angering cystic fibrosis drug advocates in UK

February 11, 2019 Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma

Despite ongoing controversy surrounding the currently stalled negotiations between Vertex and the NHS to make its cystic fibrosis (CF) drug …
News

Scientists identify alcoholism gene

February 11, 2019 Research and Development, Sales and Marketing Alcohol misuse, alcoholism, ethanol, oregon, research

Scientists at the Oregon Health & Science University (OSHU) in Portland have identified a gene which may play a fundamental …
News

UCB teams up with charity to beat treatment-resistant epilepsy in $2.5m partnership

February 11, 2019 Research and Development, Sales and Marketing Epilepsy Society, UCB Pharma, epilepsy, pharma

Belgian firm UCB Pharma has announced a new partnership with the charity Epilepsy Society which will see the pair invest …
News

Diet drugs supress appetite in mosquitoes, study shows

February 11, 2019 Sales and Marketing Zika, dengue, infectuous diseases, malaria, mosquitoes

Scientists were able to supress mosquitoes appetites using diet drugs for humans, according to research published in the journal Cell. …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026